Catalyst Wire Dossier Catalyst Wire Dossier

EA5

· Shanghai Lanyi Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EA5, covering 2025-12-01 to 2025-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects [Phase 1]

See pricing